Clinical Trials Logo

Clinical Trial Summary

This is a randomized double-blinded study to investigate in which the groups are designated as the control group and the goal-directed fluid therapy group to further evaluate significant differences in rate of complications during burn surgery.


Clinical Trial Description

This is a randomized double-blinded study to investigate the effect of control group and the goal-directed fluid therapy group on complications during surgery of the burn patients. The groups are designated as the control group and the oal-directed fluid therapy group to further evaluate significant differences in complications during the surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05241912
Study type Interventional
Source Guangzhou Red Cross Hospital
Contact
Status Not yet recruiting
Phase Early Phase 1
Start date February 28, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Terminated NCT00974597 - Comparison of AWBAT™-D and MEPILEX® AG for Treatment of Donor Sites in Burn Surgery N/A
Recruiting NCT03590873 - The Effect of Restrictive Fluid and Vasopressin During Surgery of Burn Patients N/A
Recruiting NCT03884036 - Effect of Vitamin D in Burn Patients N/A